| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.0B | $11.3B | $14.8B | $17.3B | $3.8B | $8.2B | $1.9B | $0.8B |
| Cost of Revenue | $10.3B | $10.6B | $14.0B | $16.6B | $12.0B | $7.8B | $7.7B | $2.7B |
| Gross Profit | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.4B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | — | $3.35 | $3.00 | $3.89 | $3.12 | $0.23 | $0.20 | $0.84 |
| EPS (Diluted) | — | $3.32 | $2.94 | $3.81 | $3.07 | $0.23 | $0.20 | $0.84 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.7B | $4.1B | $3.9B | $4.6B | $4.6B | $4.3B | $3.9B | $2.4B |
| Current Assets | $2.4B | $2.9B | $2.8B | $3.5B | $3.4B | $2.4B | $1.9B | $1.0B |
| Cash & Equivalents | $0.1B | $0.6B | $0.6B | $0.1B | $0.2B | $0.0B | $0.1B | $0.0B |
| Total Liabilities | $2.4B | $2.5B | $2.3B | $3.2B | $3.3B | $3.1B | $2.7B | $1.5B |
| Current Liabilities | $1.7B | $1.7B | $1.6B | $2.5B | $2.5B | $1.9B | $1.4B | $0.8B |
| Stockholders' Equity | $1.2B | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.3B | $0.9B | $0.3B | $-0.1B | $-0.1B | $0.3B | $-0.0B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $-0.1B | $0.5B | $-0.1B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.3B | $-0.3B | $-0.2B | $0.1B | $0.0B | $0.2B |